Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

David Crean

David Crean is chief business officer at MedicNova.

Articles by David Crean

David Crean

How Pharma is Adjusting Strategies for Changing Dynamics at FDA

ByMike Hollan,David Crean

May 18th 2026

David Crean, chief business officer at MedicNova, discusses changes at FDA causing variability and unpredictability in regulatory approvals.

Latest Updated Articles

Trending on PharmExec

Pharmaceutical Executive Daily: FDA Approves AstraZeneca's Fasenra

John Oyler: Rewiring Operations in Oncology

Beyond the Molecule: The New Competitive Battlefield in Oncology

FDA Approves Fasenra for Hypereosinophilic Syndrome

The Relationship Between the Capital Markets and Biotech?